IFN-ε is being studied for the treatment of viral diseases including condyloma acuminatum, verruca vulgaris, laryngeal papilloma, cervical cancer and other diseases caused by human papilloma virus infection, female genitourinary infections and some tumors. The gene discussed is IFNE; the disease is cervical cancer.